These offer a benefit above peptide vaccines because they contain both equally HLA class I and II epitopes and therefore are usually not subject matter to HLA restrictions. Additionally, they will appreciably activate T cells, resulting in an enhanced immune response and far better T mobile activation. While this strategy https://www.directivepublications.org/journal-of-clinical-breast-cancer/